TEAM.NASDAQAtlassian CORP

Form 4: Atlassian Co-Founder Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Atlassian Co-Founder and CEO Michael Cannon-Brookes reported multiple sales of Class A Common Stock totaling 7,665 shares on November 21, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

  • Michael Cannon-Brookes, Atlassian's Co-Founder, CEO, Director, and 10% Owner, reported sales of Class A Common Stock.
  • The transactions occurred on November 21, 2025.
  • A total of 7,665 shares were sold across seven separate transactions.
  • The sales were executed pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
  • Weighted-average prices for the sales ranged from $140.662 to $146.3636 per share.
  • Following these transactions, Michael Cannon-Brookes indirectly beneficially owns 199,290 shares of Class A Common Stock through CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.

Sentiment

Score: 5

Explanation: This is a routine insider sale under a pre-arranged 10b5-1 plan, which is generally considered a neutral event.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

This is a routine insider transaction and does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

  • Shareholders may note a reduction in direct beneficial ownership by a key executive, though this is a pre-planned sale under a 10b5-1 plan and typically does not indicate a change in company fundamentals.

Key Dates

DateDescription
02/20/2025Rule 10b5-1 trading plan adopted by Michael Cannon-Brookes.
11/21/2025Date of reported Class A Common Stock sales.
11/24/2025Date Form 4 was signed.

Recommendation

hold

The filing reports a routine sale of shares by a key executive under a pre-arranged 10b5-1 trading plan. Such planned sales are common for executives for diversification and liquidity purposes and do not typically signal a change in the company's fundamentals or future prospects. Therefore, the filing itself does not warrant a change in investment recommendation.

Keywords

Atlassian, TEAM, Michael Cannon-Brookes, insider trading, Form 4, stock sale, 10b5-1 plan, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.